Role of the interfacial binding domain in the oxidative susceptibility of lecithin:cholesterol acyltransferase

Biochemical Journal

Volumn 365, Issue 3, 2002, Pages 649-657

  Wang, Kewei ^a   Subbaiah, Papasani V ^a  

^a RUSH MEDICAL COLLEGE   (United States)

Author keywords

Cysteine; Esterase; Oxidized phospholipids; Phospholipase A2; Tryptophan

Indexed keywords

ESTERIFICATION; HYDROLYSIS; HYDROPHOBICITY; MUTAGENESIS; OXIDATION; PHOSPHOLIPIDS;

AROMATIC RESIDUES;

ENZYMES;

PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PHOSPHOLIPASE A2; TRYPTOPHAN;

ARTICLE; CHOLESTEROL ESTERIFICATION; DETOXIFICATION; ENZYME INACTIVATION; ENZYME SUBSTRATE COMPLEX; LIPID OXIDATION; MOLECULAR INTERACTION; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS;

ANIMALS; BINDING SITES; CHO CELLS; CHOLESTEROL; CRICETINAE; CYSTEINE; ESTERIFICATION; HUMANS; MUTAGENESIS, SITE-DIRECTED; OXIDATION-REDUCTION; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; PHOSPHATIDYLCHOLINES; PROTEIN BINDING; TRYPTOPHAN;

EID: 0036683671     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20020064     Document Type: Article

References (40)

1. The oxidative modification hypothesis of atherosclerosis: Does it hold for humans?
2. The plasma lecithin:cholesterol acyltransferase reaction
3. Copper and gas-phase cigarette smoke inhibit plasma lecithin:cholesterol acyltransferase activity by different mechanisms
4. Effect of peroxyl radicals on lecithin:cholesterol acyltransferase activity in human plasma
5. Minimally oxidized LDL is a potent inhibitor of lecithin:cholesterol acyltransferase activity
6. Modification of LCAT activity and HDL structure: New links between cigarette smoke and coronary heart disease risk
7. Disparate effects of oxidation on plasma acyltransferase activities: Inhibition of cholesterol esterification but stimulation of transesterification of oxidized phospholipids
8. Importance of the free sulfhydryl groups of lecithin-cholesterol acyltransferase for its sensitivity to oxidative inactivation
9. Identification of a domain of lecithin-cholesterol acyltransferase that is involved in interfacial recognition
10. Characterization of functional residues in the interfacial recognition domain of lecithin cholesterol acyltransferase (LCAT)
11. Early destruction of tryptophan residues of apolipoprotein B is a vitamin E-independent process during copper-mediated oxidation of LDL
12. Altered positional specificity of human plasma lecithin-cholesterol acyltransferase in the presence of sn-2 arachidonoyl phosphatidylcholines. Mechanism of formation of saturated cholesteryl esters
13. 2 and transacylase fatty acyl specificity
14. Characterization of proteoliposomes containing apoprotein A-I: A new substrate for the measurement of lecithin:cholesterol acyltransferase activity
15. Activation of plasma lysolecithin acyltransferase reaction by apolipoproteins A-I, C-I and E
16. A rapid method of total lipid extraction and purification
17. Hydrolysis and transesterification of platelet-activating factor by lecithin-cholesterol acyltransferase
18. Reaction of lecithin:cholesterol acyltransferase with water-soluble substrates
19. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples
20. Chromatographic separation, identification and analysis of phosphatides
21. Release of fatty acids and phosphatidylcholine by lecithin-cholesterol acyltransferase
22. Novel function of lecithin-cholesterol acyltransferase - Hydrolysis of oxidized polar phospholipids generated during lipoprotein oxidation
23. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo
24. Lipid ester-bound aldehydes among copper-catalyzed peroxidation products of human plasma lipoproteins
25. Structural identification of phosphatidylcholines having an oxidatively shortened linoleate residue generated through its oxygenation with soybean or rabbit reticulocyte lipoxygenase
26. Evidence that lipid hydroperoxides inhibit plasma lecithin:cholesterol acyltransferase activity
27. Mutation of tryptophan residues in lipoprotein lipase. Effects on stability, immunoreactivity and catalytic properties
28. A proposed architecture for lecithin:cholesterol acyltransferase (LCAT): Identification of the catalytic triad and molecular modeling
29. The preference of tryptophan for membrane interfaces
30. Direct evidence for apo B-100-mediated copper reduction: Studies with purified apo B-100 and detection of tryptophanyl radicals
31. Metabolism of oxidized phosphatidylcholines formed in oxidized low density lipoprotein by lecithin-cholesterol acyltransferase
32. Lipids and the endothelium
33. Possible induction of renal dysfunction in patients with lecithin:cholesterol acyltransferase deficiency by oxidized phosphatidylcholine in glomeruli
34. PAF-acether-degrading acetylhydrolase in plasma LDL is inactivated by copper- and cell-mediated oxidation
35. Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor
36. Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities. Selective action of human paraoxonase alloenzymes Q and R
37. Copper- and malondialdehyde-induced modification of high density lipoprotein and parallel loss of lecithin:cholesterol acyltransferase activation
38. Distribution and functions of lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in plasma lipoproteins. Evidence for a functional unit containing these activities together with apolipoproteins A-I and D that catalyzes the esterification and transfer of cell-derived cholesterol
39. Distribution of lecithin-cholesterol acyltransferase (LCAT) in human plasma lipoprotein fractions. Evidence for the association of the active enzyme with low density lipoproteins
40. In vitro mass:activity distribution of lecithin-cholesterol acyltransferase among human plasma lipoproteins